Related Experiment Video
Updated: May 6, 2026
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Evaluation of three APTT reagents in a routine laboratory: toward a compromise
Laurence Rozen1, Florian Copette, Denis F Noubouossie
1Laboratory of Hematology and Haemostasis, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium. laurence.rozen@chu-brugmann.be
Background:
Our current activated partial thromboplastin time (APTT) reagent (PTT-A) is often prolonged for unexplained reasons.
Methods:
We decided to compare this reagent with an alternative reagent (Cephascreen) and with our second line APTT (Actin FS) in terms of cut-off values, sensitivity to in-vitro coagulation factor deficiencies, sensitivity to lupus anticoagulant (LA), and in vivo sensitivity to unfractionated heparin (UFH).
Results:
Actin FS, PTT-A, and Cephascreen were prolonged for FVIII level at 60%, 40%, and 40% respectively, FIX at 50%, 25%, and 35%, and FXI at 60%, 20%, and 50%. PTT-A showed the same sensitivity and specificity as Cephascreen to LA. Actin FS and PTT-A appeared less suitable to monitor UFH regarding the CLSI criteria.
Conclusions:
Cephascreen fulfilled the CLSI performance criteria, with a good compromise in terms of sensitivity to factor deficiency and with a substantial reduction of complementary analysis in our routine practice.
